Skip to main content
SpringerLink
Log in

Proteomics

  • Chapter
Molecular Pathology of Lung Diseases

Part of the book series: Molecular Pathology Library ((MPLB,volume 1))

  • 2118 Accesses

Abstract

The establishment of a complete human genome sequence has opened a new era in biology referred to as omics. The term designates a complete analysis of biologic systems in which entire metabolic pathways are studied. This new methodologic approach becomes possible because of the dynamic development of advanced instrumentation unique for each of the omics subdisciplines. By increasing analytical sensitivity and through transformation into high-throughput analysis, such technologies as DNA and protein microarray or mass spectrometry have become a driving force for omics research. The amount of information derived from omics disciplines has in turn stimulated the development of bioinformatics. By improving the methods of storage and analysis of large amounts of data, an improved system of bioinformatics allows efficient exchange of information among researchers and contributes significantly to the development of omics disciplines. Despite its short history, this new methodology has proved its effectiveness by advancing our understanding of biologic processes, which brings hope for more accurate diagnosis and treatment of diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720–1730.

    CAS  PubMed  Google Scholar 

  2. Karin DR. Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin Biochem 2004;37:579–583.

    Article  Google Scholar 

  3. Patterson DS. Proteomics: beginning to realize its promise? Arthritis Rheum 2004;12:3741–3744.

    Article  Google Scholar 

  4. Check E. Proteomics and cancer: running before we can walk? Nature 1004;429(6991):496–497.

    Article  Google Scholar 

  5. Petricoin III FE, Ardekani MA, Hitt AB, et al. Use of proteomics patterns in serum to identify ovarian cancer. Lancet 2002;359:572–577

    Article  CAS  PubMed  Google Scholar 

  6. Henzel WJ, Stults JT, Wong SC, et al. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA 1993;90:5011–5015.

    Article  CAS  PubMed  Google Scholar 

  7. Moritz B, Meyer HE. Approaches for the quantification of protein concentration ratios. Proteomics 2003;3:2208–2220.

    Article  CAS  PubMed  Google Scholar 

  8. Consoli L, Damerval C. Quantification of individual zein isoforms resolved by two-dimensional electrophoresis: genetic variability in 45 maize inbred lines. Electrophoresis 2001;22:2983–2989.

    Article  CAS  PubMed  Google Scholar 

  9. Thiedea B, Höhenwarterb W, Kraha A, et al. Peptide mass fingerprinting. Methods 2005;35:237–247.

    Article  Google Scholar 

  10. Godovac-Zimmermann J, Kleiner O, Brown RL, Drukier KA. Perspectives in spicing up proteomics with splicing. Proteomics 2005;5:699–709.

    Article  CAS  PubMed  Google Scholar 

  11. Karas M, Bachnann D, Bahr U, Hillenkamp F, Matrix. Assisted ultraviolet laser desorption of non-volatile compounds. Int J Mass Spectrom Ion Process 1987;78:53–68.

    Article  CAS  Google Scholar 

  12. Burtis AC, Ashwood RE, Burns D. Tietz Textbook of Clinical Chemistry and Molecular Diagnosis, 4th ed. Philadelphia: Elsevier; 2006:170.

    Google Scholar 

  13. Loboda AV, Krutchinsky AN, Bromirski M, et al. A tandem quadrupole/time-of-flight mass spectrometer with a matrixassisted laser desorption/ionization source: design and performance. Rapid Commun Mass Spectrom 2000;14:1047–1057.

    Article  CAS  PubMed  Google Scholar 

  14. Chaurand P, Caprioli MR. Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry. Electrophoresis 2002;23:3125–3135.

    Article  CAS  PubMed  Google Scholar 

  15. Stoeckli M, Farmer TB, Caprioli RM. Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument. J Am Soc Mass Spectrom 1999;10(1):67–71.

    Article  CAS  PubMed  Google Scholar 

  16. Poetz O, Schwenk MJ, Kramer S, et al. Protein microarrays: catching the proteome. Mech Ageing Dev 2005;126:161–170.

    Article  CAS  PubMed  Google Scholar 

  17. Petricoin E, Paweletz C, Liotta L. Clinical applications of proteomics: proteomic pattern diagnostics. J Mammary Gland Biol Neoplasia 2002;7:433–440.

    Article  PubMed  Google Scholar 

  18. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572–577.

    Article  CAS  PubMed  Google Scholar 

  19. Petricoin EI, Ornstein D, Paweletz C, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576–1578.

    CAS  PubMed  Google Scholar 

  20. Zhang L, Rosenzweig J, Wang Y, Chan D. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296–1304.

    PubMed  Google Scholar 

  21. Rodland DK. Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin Bioch 2004;37:579–583.

    Article  CAS  Google Scholar 

  22. Reinders J, Lewandrowski U, Moebius J, et al. Challenges in mass spectrometry-based proteomics. Proteomics 2004;4:3686–3703.

    Article  CAS  PubMed  Google Scholar 

  23. Schrader W, Klein WH. Liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry (LC-FTICR MS): an early overview. Anal Bioanal Chem 2004;379:1013–1024.

    Article  CAS  PubMed  Google Scholar 

  24. Johnsona RS, Davisa MT, Taylorb JA, Pattersona SD. Informatics for protein identification by mass spectrometry. Methods 2005;35:223–236.

    Article  Google Scholar 

  25. Papayannopoulos IA. The analysis of progressive spectra yields information about the amino acid sequence for the chosen peptide. Mass Spectrom Rev 1995;14:49–73.

    Article  CAS  Google Scholar 

  26. Thiedea B, Höhenwarterb W, Kraha A, et al. Peptide mass fingerprinting. Methods 2005;35:237–247.

    Article  Google Scholar 

  27. Schmidt F, Schmid M, Jungblut PR, et al. Iterative data analysis is the key for exhaustive analysis of peptide mass fingerprints from proteins separated by two-dimensional electrophoresis J Am Soc Mass Spectrom 2004;14:943–956.

    Article  Google Scholar 

  28. Tabb LD, Smith LL, Breci AL, et al. Statistical characterization of ion trap tandem mass spectra from doubly charged tryptic peptides. Anal Chem 2003;75:1155–1163.

    Article  CAS  PubMed  Google Scholar 

  29. Shadforth I, Crowther D, Bessant C. Protein and peptide identification algorithms using MS for use in high-throughput, automated pipelines. Proteomics 2005;5:4082–4095.

    Article  CAS  PubMed  Google Scholar 

  30. Gygi SP, Corthals GL, Zhang Y, et al. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 2000;97:9390–9395.

    Article  CAS  PubMed  Google Scholar 

  31. Kleiner O, Price DA, Ossetrova N, et al. Ultra-high sensitivity multi-photon detection imaging in proteomics analyses. Proteomics 2005;5(9):2322–2330.

    Article  CAS  PubMed  Google Scholar 

  32. Mann M. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 2002;20:261–268.

    Article  CAS  PubMed  Google Scholar 

  33. MacCoss M J. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci USA 2002;99:7900–7905.

    Article  CAS  PubMed  Google Scholar 

  34. Galvani M, Hamdan M, Herbert B, Righetti GP. Alkylation kinetics of proteins in preparation for two-dimensional maps: a matrix assisted laser desorption/ionization-mass spectrometry investigation. Electrophoresis 2001;22:2058–2065.

    Article  CAS  PubMed  Google Scholar 

  35. Rotheneder H, Geymayer S, Haidweger E. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J Mol Biol 1999;293:1005–1015.

    Article  CAS  PubMed  Google Scholar 

  36. Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 2005;32:169–176.

    Article  CAS  PubMed  Google Scholar 

  37. Chanin TD, Merrick DT, Franklin WA, Hirsch FR. Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present. Curr Opin Pulm Med 2004;10(4):242–247.

    Article  CAS  PubMed  Google Scholar 

  38. Noël-Georis I, Bernard A, Falmagne P, Wattiez R. Proteomics as the tool to search for lung disease markers in bronchoalveolar lavage. Dis Markers 2001;17(4):271–284.

    PubMed  Google Scholar 

  39. Houtman R, van den Worm E. Asthma, the ugly duckling of lung disease proteomics? J Chromatograph B 2005;815(1–2):285–294.

    Article  CAS  Google Scholar 

  40. Hirsch J, Hansen KC, Burlingame AL, Matthay MA. Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 2004;287:1–23.

    Article  Google Scholar 

  41. Malmström J, Larsen K, Malmström L, et al. Proteome annotations and identifications of the human pulmonary fibroblast. J Proteome Res 2004;3(3):525–537.

    Article  PubMed  Google Scholar 

  42. Sepper R, Prikk K. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res 2004;3(2):277–281.

    Article  CAS  PubMed  Google Scholar 

  43. Merkel D, Rist W, Seither P, et al. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surfaceenhanced laser desorption/ionization—mass spectrometry profiling with mass spectrometric protein identification. Proteomics 2005;5(11):2972–2980.

    Article  CAS  PubMed  Google Scholar 

  44. Pollard HB, Ji X-D, Jozwik C, Jacobowitz DM. High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics 2005;8:2210–2226.

    Article  Google Scholar 

  45. Kriegova E, Melle C, Kolek V, et al. Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2006;173:1145–1154.

    Article  CAS  PubMed  Google Scholar 

  46. Drake RR, Deng Y, Schwegler EE, Gravenstein S. Proteomics for biodefense applications: progress and opportunities. Expert Rev Proteomics 2005;2(2):203–213.

    Article  CAS  PubMed  Google Scholar 

  47. Kang X, Xu Y, Wu X. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 2005;51(1):56–64.

    Article  CAS  PubMed  Google Scholar 

  48. Srivastava S, Verma M, Gopal-Srivastava R. Proteomic maps of the cancer-associated infectious agents. J Proteome Res 2005;4:1171–1180.

    Article  CAS  PubMed  Google Scholar 

  49. Gimino VJ, Lande JD, Berryman TR, et al. Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection. Am J Respir Crit Care Med 2003;168:1237–1242.

    Article  PubMed  Google Scholar 

  50. Nelsestuen GL, Michael B, Martinez MB, et al. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 2005;5(6):1705–1713.

    Article  CAS  PubMed  Google Scholar 

  51. Xiao X, Liu D, Tang Y, Guo et al. Development of proteomic patterns for detecting lung cancer. Dis Markers 2003–2004;19(1):33–39.

    CAS  PubMed  Google Scholar 

  52. Robinson BWS, Creaney J, Lake R, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003;362(9396):1612–1616.

    Article  CAS  PubMed  Google Scholar 

  53. Zhukov TA, Johanson RA, Cantor AB. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003;40:267–279.

    PubMed  Google Scholar 

  54. Yanagisawa K, Shyr Y, Xu BJ. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;362:433–439.

    Article  CAS  PubMed  Google Scholar 

  55. Campa MJ, Wang MZ, Howard B, et al, Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin as potential molecular targets in non-small cell lung cancer. Cancer Res 2003, 63:1652–1656.

    CAS  PubMed  Google Scholar 

  56. Fowler LJ, Lovell MO, Izbicka E. Fine-needle aspiration in PreservCyt®: a novel and reproducible method for ancillary proteomic pattern evaluation of breast neoplasms by SELDI-TOF. Mod Pathol 2004;17:1012–1020.

    Article  CAS  PubMed  Google Scholar 

  57. Tyan YC, Wu HY, Su WC, et al. Proteomic analysis of human pleural effusion. Proteomics 2001;5(4):1062–1074.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

    Larry Fowler MD (Professor) & Wieslaw Furmaga MD (Assistant Professor)

Authors
  1. Larry Fowler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wieslaw Furmaga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

    Dani S. Zander MD

  2. Institute of Pathology, Laboratories for Molecular Cytogenetics, Medical University of Graz, Graz, Austria

    Helmut H. Popper MD

  3. Department of Pathology, University of Texas Health Science Center, San Antonio, TX, USA

    Jaishree Jagirdar MD

  4. Weill Medical College of Cornell University, New York, NY

    Abida K. Haque MD

  5. Department of Pathology, San Jacinto Methodist Hospital, Baytown, TX, USA

    Abida K. Haque MD

  6. Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY

    Philip T. Cagle MD  & Roberto Barrios MD  & 

  7. The Methodist Hospital, Houston, TX, USA

    Philip T. Cagle MD  & Roberto Barrios MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC.

About this chapter

Cite this chapter

Fowler, L., Furmaga, W. (2008). Proteomics. In: Zander, D.S., Popper, H.H., Jagirdar, J., Haque, A.K., Cagle, P.T., Barrios, R. (eds) Molecular Pathology of Lung Diseases. Molecular Pathology Library, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72430-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-72430-0_13

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-72429-4

  • Online ISBN: 978-0-387-72430-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation